Deutsche Bank Ag\ P Lx Pharma Inc. Transaction History

Deutsche Bank Ag\

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 14, 2020	SELL	$1.98 - $5.87 $780 - $2,312	-394 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$3.36 - $5.04 $1,323 - $1,985	394 New	394 $1,000
Q3 2019 Nov 14, 2019	SELL	$4.89 - $7.18 $6,357 - $9,334	-1,300 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$4.93 - $7.2 $493 - $720	100 Added 8.33%	1,300 $9,000
Q1 2019 May 15, 2019	BUY	$2.05 - $6.0 $2,460 - $7,200	1,200 New	1,200 $6,000

Q4 2018 Feb 14, 2019	SELL	$1.22 - $4.38 $5,130 - $18,417	-4,205 Closed	0 $0
Q3 2018 Dec 21, 2021	SELL	$3.18 - $5.15 $6 - $10	-2 Reduced 0.05%	4,205 $17,000
Q3 2018 Nov 14, 2018	BUY	$3.18 - $5.15 $13,371 - $21,655	4,205 Added 210250.0%	4,207 $17,000
Q3 2017 Nov 14, 2017	BUY	$6.08 - $7.0 $12 - $14	2	2 $0

61.6K

Ticker PLXP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 29,137,700
Description
PLx Pharma Inc. operates as a commercial-stage drug delivery platform technology company in the United States. The company's lead product candidates are Vazalore 325 mg for the patients with vascular events, such as heart attacks and clot-related strokes, as well as for use in conditions associated with pain and inflammation, including other asp...

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

Stay updated on Deutsche Bank Ag\ with notifications on news.